UK healthtechaccuRx, which helped arrange 21 million COVID-19 vaccines, raised £ 27.5m

When it comes to patient care, patients in almost every healthcare system in the world often fragment and feel communication. Addressing this challenge in the growing $ 8.3 trillion global healthcare industry, accuRx Provides the first Kyodo communication platform to connect patients with their medical teams as a key step in integrating care.

Digital transformation in healthcare

Now based in London Health Tech Startup accuRx has announced that it has raised £ 27.5m in a Series B funding round to lead digital transformation in healthcare. NS investment The round was led by Lakestar and was attended by British Patient Capital, Latitude VS (a sister fund of London-based seed investor Local Globe), Atomico, Trusted Insight and Encore Capital.

The new funding will drive the growth of the accuRx team, strengthen its delivery to GP practice, and build products that will allow it to expand into secondary care.

Dr. David Triska, GP Partner of Witley and Milford Surgeries, commented: We are also excited about the advancement of accuRx to secondary care, as the better interaction between primary and secondary care is a major step towards safer and more effective patient care. “

“We are proud that accuRx has been able to achieve this by transforming communication within primary care, and we can’t wait to see the significant benefits that the tool can bring to secondary care as well. With its suite of products, accuRx has the potential to become an important backbone and infrastructure for the global healthcare market, “said Lakestar partner Oliver Himes.

“We have spent an early part of building accuRx shadowing healthcare staff in surgery in Oxford, so we have a great deal of emphasis on user research. By working closely with our users, they can work with each other. , And learn how to build powerful and intuitive software to communicate with your patients. This latest funding round is the incredible work the team has done and the future ahead. We are demonstrating an opportunity, “said Jacob Hadad, CEO and co-founder of accuRx.

“For the past 18 months, we have provided work to support users throughout the pandemic, including remote consultation and building a reservation system for the nationwide COVID-19 vaccination program. Last year we grew our team from less than 50 to more than 110 accuFolks. This funding allows us to hire more people to support our vision. CTO and co-founder of accuRx Laurence Bargery said:

Joint medical communication platform

Founded by Jacob Haddad and Laurence Bargery through a pandemic, accuRx played a key role in supporting front-line medical staff, earning a world-class user satisfaction score of 88. Patients with COVID-19 symptoms. Additional features include asynchronous messaging, with 2 million patients being contacted weekly via accuRx.

It took just four weeks to build a vaccine reservation system and is now used to manage more than 21 million COVID-19 vaccinations. This is more than a quarter of all vaccines offered in the UK. accuRx provides the first collaborative communication platform to connect patients with their medical teams. This is an important step in integrating care. Today, accuRx software is used by 98% of UK general practitioners and is gaining increasing trust in hospitals and communities to communicate with patients and each other.

UK healthtechaccuRx, which helped arrange 21 million COVID-19 vaccines, raised £ 27.5m

Source link UK healthtechaccuRx, which helped arrange 21 million COVID-19 vaccines, raised £ 27.5m

Exit mobile version